← NATIONAL HEALTH INVESTORS INC NHI
Market Price
$72.91
Market Cap
$3.45B
P/E Ratio
24.14
Revenue (FY 2025)
↑47.1% YoY
$80.06M
3-Yr CAGR: 30.8%
Net Income
↑3.0% YoY
$142.18M
Net Margin: 177.6%
Free Cash Flow
↓-215.3% YoY
-$57.47M
FCF Yield: -1.66%
EPS (Diluted)
↓-3.5% YoY
$3.02
Basic: $3.03
Return on Equity
Efficiency
9.3%
ROA: 5.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (NHI)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $248.5M | — | $205.4M | $151.5M | — | $3.87 | — | $177.2M | $-217.5M | — |
| FY 2017 | $278.7M | +12.1% | $232.3M | $159.4M | +5.2% | $3.87 | 0.0% | $197.3M | $21.5M | +109.9% |
| FY 2018 | $294.6M | +5.7% | $245.6M | $154.3M | -3.2% | $3.67 | -5.2% | $207.9M | $60.2M | +179.7% |
| FY 2019 | $318.1M | +8.0% | $261.8M | $160.5M | +4.0% | $3.67 | 0.0% | $241.0M | $3.8M | -93.7% |
| FY 2020 | $332.8M | +4.6% | $279.9M | $185.1M | +15.4% | $4.14 | +12.8% | $232.1M | $115.4M | +2,962.5% |
| FY 2021 | $298.7M | -10.2% | $247.9M | $111.8M | -39.6% | $2.44 | -41.1% | $210.9M | $160.5M | +39.1% |
| FY 2022 | $35.8M | -88.0% | $35.8M | $66.4M | -40.6% | $1.48 | -39.3% | $185.3M | $174.3M | +8.6% |
| FY 2023 | $48.8M | +36.4% | $19.5M | $135.7M | +104.3% | $3.13 | +111.5% | $184.4M | $134.9M | -22.6% |
| FY 2024 | $54.4M | +11.5% | $54.4M | $138.0M | +1.7% | $3.13 | 0.0% | $207.8M | $49.8M | -63.1% |
| FY 2025 | $80.1M | +47.1% | $22.7M | $142.2M | +3.0% | $3.02 | -3.5% | $236.6M | $-57.5M | -215.3% |
Valuation
Market Price
$72.91
Market Cap
$3.45B
Enterprise Value
N/A
P/E Ratio
24.14
P/B Ratio
2.32
FCF Yield
-1.66%
Dividend Yield
4.99%
Shares Outstanding
Profitability & Margins
Gross Margin
28.35%
Operating Margin
177.58%
Net Margin
177.58%
Return on Equity (ROE)
9.34%
Return on Assets (ROA)
5.08%
Asset Turnover
0.03x
Revenue 3-Yr CAGR
30.78%
Financial Health & Liquidity
Current Ratio
N/A
Cash Ratio
N/A
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$19.62M
Total Debt
N/A
Book Value / Share
$31.39
Cash Flow Efficiency
Operating Cash Flow
$236.56M
Capital Expenditures (CapEx)
$294.03M
Free Cash Flow
-$57.47M
OCF / Revenue
295.47%
FCF / Revenue
-71.78%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$3.02
EPS (Basic)
$3.03
Dividends / Share
$3.64
Book Value / Share
$31.39
EPS YoY Growth
-3.51%
Balance Sheet (FY 2025)
Total Assets
$2.80B
Total Liabilities
$1.26B
Stockholders' Equity
$1.52B
Current Assets
N/A
Current Liabilities
N/A